$19.65
0.65[3.42%]
At close: Apr 26
$19.65
0[0.00%]
After Hours: 4:20PM EDT
Kura Oncology
(NASDAQ:KURA)Latest News for Kura Oncology Stock (NASDAQ:KURA)
Kura Oncology Stock (NASDAQ: KURA)
Categories: All
Monday, April 22, 2024
- HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $32 Price TargetBenzinga Newsdesk - 4 days ago
- Kura Oncology shares are trading higher after the company received FDA Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML.Benzinga Newsdesk - 4 days ago
- Kura Oncology's Ziftomenib, Has Been Granted FDA Breakthrough Therapy Designation For Relapsed/Refractory NPM1-mutant Acute Myeloid LeukemiaBenzinga Newsdesk - 4 days ago
Wednesday, March 06, 2024
- HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $32 Price TargetBenzinga Newsdesk - Mar 6, 2024, 12:01PM
- Kura Oncology shares are trading higher after the company announced that it dosed its first patient in its trial of KO-2806 plus cabozantinib in renal cell carcinoma.Benzinga Newsdesk - Mar 6, 2024, 11:51AM
- Kura Oncology Reports First Patient Dosed In Trial Of KO-2806 Plus Cabozantinib In Renal Cell CarcinomaBenzinga Newsdesk - Mar 6, 2024, 7:33AM
Wednesday, February 28, 2024
Tuesday, February 27, 2024
Monday, February 26, 2024
- Earnings Outlook For Kura OncologyBenzinga Insights - Feb 26, 2024, 12:01PM
- Kura Oncology Has Dosed The First Patient In KOMET-008 Phase 1 Trial Of Ziftomenib, In Combination With Gilteritinib, FLAG-IDA, Or LDAC For NPM1-Mutant Or KMT2A-Rearranged Acute Myeloid LeukemiaBenzinga Newsdesk - Feb 26, 2024, 7:42AM
Wednesday, January 31, 2024
Tuesday, January 30, 2024
- Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Jan 30, 2024, 1:18PM
- Why Cancer-Drug Developer Kura Oncology Stock Is UpErica Kollmann - Jan 30, 2024, 11:15AM
- Kura Oncology shares are trading higher after the company reported preliminary clinical data from the first 20 patients in KOMET-007.Benzinga Newsdesk - Jan 30, 2024, 11:07AM
- General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - Jan 30, 2024, 10:09AM
- Kura Oncology Reports Preliminary Ziftomenib Combination Data in Acute Myeloid LeukemiaBenzinga Newsdesk - Jan 30, 2024, 7:01AM
Wednesday, January 24, 2024
- Dow Edges Lower; US Composite PMI Rises In JanuaryAvi Kapoor - Jan 24, 2024, 3:46PM
- Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Jan 24, 2024, 1:05PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jan 24, 2024, 12:31PM
- Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?Vandana Singh - Jan 24, 2024, 11:16AM
- Kura Oncology shares are trading higher after the company announced an oversubscribed $150 million private placement.Benzinga Newsdesk - Jan 24, 2024, 10:32AM
- Textron Posts Upbeat Earnings, Joins ASML, Progressive And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Jan 24, 2024, 10:08AM
- Market-Moving News for January 24thBenzinga Newsdesk - Jan 24, 2024, 8:34AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jan 24, 2024, 8:05AM
- Kura Oncology Announces Oversubscribed $150M Private PlacementBenzinga Newsdesk - Jan 24, 2024, 7:04AM
Friday, December 22, 2023
- Clinical Advancements In Kura Oncology's Lead Program Ziftomenib Hint at Upsurge in Success Likelihood: AnalystVandana Singh - Dec 22, 2023, 12:50PM
- Kura Oncology shares are trading higher after Mizuho initiated coverage on the stock with a Buy rating and announced a $26 price target.Benzinga Newsdesk - Dec 22, 2023, 11:10AM
- Mizuho Initiates Coverage On Kura Oncology with Buy Rating, Announces Price Target of $26Benzinga Newsdesk - Dec 22, 2023, 7:23AM
Friday, December 08, 2023
- HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $32 Price TargetBenzinga Newsdesk - Dec 8, 2023, 9:47AM
- Kura Oncology Says Its Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society's Pediatric Acute Leukemia (PedAL) Master Clinical TrialBenzinga Newsdesk - Dec 8, 2023, 7:32AM
Monday, November 27, 2023
Friday, November 03, 2023
Thursday, November 02, 2023
- Kura Oncology Q3 2023 Gaap EPS $(0.50) Beats $(0.55) EstimateBenzinga Newsdesk - Nov 2, 2023, 4:13PM
- Kura Oncology And Mirati Therapeutics Enter Into Clinical Collaboration And Supply Agreement To Evaluate KO-2806 And Adagrasib For Non-small Cell Lung CancerBenzinga Newsdesk - Nov 2, 2023, 7:55AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Thursday, October 19, 2023
Wednesday, October 18, 2023
Tuesday, October 17, 2023
Tuesday, October 03, 2023
Thursday, September 28, 2023
- Curaleaf CIO, Camilo Lyon Says 'Brand Also Entails Customer Experience, Says Brands Matter To Consumers'Benzinga Newsdesk - Sep 28, 2023, 11:31AM
- Kura Oncology Reports Preclinical Data Showing Ability Of KO-2806 To Enhance Antitumor Activity of KRASᴳ¹²ᶜ Inhibitors In Non-Small Cell Lung CancerBenzinga Newsdesk - Sep 28, 2023, 7:32AM